WEBULL

Aethlon Medical Files For Common Stock Offering Of $15M

Benzinga · 1d ago

$15,000,000

 

Common Stock

 

From time to time, we may offer and sell shares of our common stock, par value $0.001 per share, with total gross proceeds of up to $15,000,000.

 

This prospectus provides a general description of the terms that may apply to an offering of our common stock. Each time we offer shares of our common stock, we will provide a supplement to this prospectus that contains specific information about the offering. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus.

 

You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference herein and therein, before you invest in our common stock.

 

Our common stock is listed on The Nasdaq Capital Market under the symbol "AEMD." On December 18, 2025, the last reported sale price for our common stock was $2.83 per share.

 

As of December 18, 2025, the aggregate market value of our outstanding common stock held by non-affiliates was $5,561,929, based upon 967,292 shares of our outstanding common stock held by non-affiliates and a price of $5.75 per share, which is the highest closing sale price of our common stock on the Nasdaq Capital Market within the prior 60 days of this prospectus. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding one-third of our "public float" (i.e., the aggregate market value of our common stock held by non-affiliates) in any 12 calendar-month period so long as our public float remains below $75.0 million. During the 12 calendar months prior to and including the date of this prospectus (but excluding this offering), we have not sold any securities in reliance on General Instruction I.B.6 of Form S-3.